🔬 The Scleroderma Drugs Market: A Landscape of Hope and Innovation

Tue, 18 Nov 2025 11:31:39 +0000

Scleroderma, or systemic sclerosis (SSc), is a rare, chronic, and complex autoimmune connective tissue disease. It is characterized by three primary pathological features: vascular damage, immune system dysfunction, and excessive fibrosis (scarring) of the skin and internal organs, such as the lungs, heart, and kidneys. This complexity means that the disease presents with diverse symptoms and severity, leading to a high degree of unmet medical need.